Published in Circulation on November 27, 2007
Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med (2010) 3.45
Electrocardiogram in Preparticipation Athletic Evaluations among Insured Youths. J Pediatr (2015) 1.38
Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations. Clin Res Cardiol (2009) 1.20
Sudden cardiac death in young athletes; a literature review and special considerations in Asia. Asian J Sports Med (2011) 1.18
The pre-participation examination for leisure time physical activity: general medical and cardiological issues. Dtsch Arztebl Int (2010) 0.93
Economic evaluation of strategies to reduce sudden cardiac death in young athletes. Pediatrics (2012) 0.89
Cardiovascular screening in adolescents and young adults: a prospective study comparing the Pre-participation Physical Evaluation Monograph 4th Edition and ECG. Br J Sports Med (2014) 0.83
Sudden death in pediatric populations. Korean Circ J (2010) 0.83
The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes: March 2009. J Athl Train (2009) 0.83
Pre-participation screening for the prevention of sudden cardiac death in athletes. World J Methodol (2013) 0.80
The pre-sports cardiovascular evaluation: should it depend on the level of competition, the sport, or the state? Pediatr Cardiol (2012) 0.79
Cardiovascular health, part 1: preparticipation cardiovascular screening. Sports Health (2009) 0.77
Sudden cardiac death in young athletes. Asian J Sports Med (2011) 0.75
Sudden Cardiac Death in Athletes. Methodist Debakey Cardiovasc J (2016) 0.75
Prevalence of Cardiovascular Disorders Among Iranian Elite Athletes. Asian J Sports Med (2016) 0.75
Improving ECG Services at a Children's Hospital: Implementation of a Digital ECG System. Int J Pediatr (2015) 0.75
Pre-competition cardiac screening in professional handball players - setting up at the EHF European Handball Championship 2010 in Austria. Wien Med Wochenschr (2011) 0.75
Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death. Pediatr Cardiol (2013) 0.75
A high school-based voluntary cardiovascular risk screening program: issues of feasibility and correlates of electrocardiographic outcomes. Pediatr Cardiol (2013) 0.75
Medico-legal perspectives on sudden cardiac death in young athletes. Int J Legal Med (2016) 0.75
Primary prevention of sudden cardiac death of the young athlete: the controversy about the screening electrocardiogram and its innovative artificial intelligence solution. Pediatr Cardiol (2012) 0.75
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med (2007) 6.22
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation (2007) 2.76
Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol (2005) 1.90
Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study. J Am Coll Cardiol (2010) 1.59
Implications of anesthesia in children with long QT syndrome. Anesth Analg (2011) 1.59
Clinical decisions. Cardiac screening before participation in sports. N Engl J Med (2013) 1.51
ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics (2005) 1.46
Time and temperature profile of catheter cryoablation of right septal and free wall accessory pathways in children. J Cardiovasc Electrophysiol (2007) 1.44
A neonate with long QT syndrome, refractory ventricular arrhythmias, and lidocaine toxicity. Anesth Analg (2012) 1.39
Electrocardiographic interpretation in athletes: the 'Seattle criteria'. Br J Sports Med (2013) 1.34
Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr (2008) 1.32
Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics (2007) 1.31
Screening for sudden cardiac death in the young: report from a national heart, lung, and blood institute working group. Circulation (2011) 1.30
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr (2010) 1.22
Managed ventricular pacing in pediatric patients and patients with congenital heart disease. Am J Cardiol (2008) 1.00
Functional status, heart rate, and rhythm abnormalities in 521 Fontan patients 6 to 18 years of age. J Thorac Cardiovasc Surg (2008) 1.00
Normal electrocardiographic findings: recognising physiological adaptations in athletes. Br J Sports Med (2013) 0.99
Pacemaker therapy in isolated congenital complete atrioventricular block. Pacing Clin Electrophysiol (2002) 0.94
Pediatric pacemaker infections: twenty years of experience. J Thorac Cardiovasc Surg (2002) 0.94
Warning symptoms and family history in children and young adults with sudden cardiac arrest. J Am Board Fam Med (2012) 0.91
Abnormal electrocardiographic findings in athletes: recognising changes suggestive of cardiomyopathy. Br J Sports Med (2013) 0.90
Guidelines for the outpatient management of complex congenital heart disease. Congenit Heart Dis (2006) 0.89
Comparison of Fontan survivors with and without pacemakers: a report from the Pediatric Heart Network Fontan Cross-Sectional Study. Congenit Heart Dis (2012) 0.88
Genotype- and mutation site-specific QT adaptation during exercise, recovery, and postural changes in children with long-QT syndrome. Circ Arrhythm Electrophysiol (2011) 0.87
Heart rate variability following neonatal heart surgery for complex congenital heart disease. Pacing Clin Electrophysiol (2006) 0.86
The roles of chronic pressure and volume overload states in induction of arrhythmias: an animal model of physiologic sequelae after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg (2005) 0.86
Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth. J Thorac Cardiovasc Surg (2008) 0.86
Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease. Br J Sports Med (2013) 0.86
Clues or miscues? How to make the right interpretation and correctly diagnose long-QT syndrome. Circulation (2007) 0.85
Protecting the heart of the American athlete: proceedings of the American College of Cardiology Sports and Exercise Cardiology Think Tank October 18, 2012, Washington, DC. J Am Coll Cardiol (2014) 0.83
Slow pathway modification for atrioventricular nodal reentrant tachycardia. Am J Cardiol (2004) 0.83
Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children? Paediatr Drugs (2010) 0.83
Cryoablation of congenital familial ectopic tachycardia with preservation of atrioventricular nodal function in an infant. J Cardiovasc Electrophysiol (2007) 0.82
Capture management efficacy in children and young adults with endocardial and unipolar epicardial systems. Europace (2004) 0.82
Pediatric cardiovascular safety: challenges in drug and device development and clinical application. Am Heart J (2012) 0.82
Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era. Heart Rhythm (2010) 0.81
Reframing the debate: Screening athletes to prevent sudden cardiac death. Heart Rhythm (2012) 0.78
Report from the Task Force of the European Society of Cardiology for the interpretation of the neonatal electrocardiogram. Cardiol Young (2002) 0.77
Substrate characterization of ventricular tachycardia in a porcine model of tetralogy of Fallot using noncontact mapping. Pacing Clin Electrophysiol (2007) 0.77
Postpericardiotomy syndrome after permanent pacemaker implantation in children and young adults. Ann Thorac Surg (2004) 0.76
Junctional rhythm in association with neuroborreliosis. Pediatr Emerg Care (2005) 0.75
Ventricular tachycardia in infants with structurally normal heart: a benign disorder. Cardiol Young (2010) 0.75
Induction of atrial fibrillation after the routine use of adenosine. Pediatr Emerg Care (2006) 0.75
Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence. J Addict Med (2016) 0.75
Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference. Am Heart J (2011) 0.75
Case scenario: anesthesia-related cardiac arrest in a child with Timothy syndrome. Anesthesiology (2012) 0.75
Recommendations for advanced fellowship training in clinical pediatric and congenital electrophysiology: a report from the training and credentialing committee of the pediatric and congenital electrophysiology society. Heart Rhythm (2013) 0.75
Mapping the critical diastolic pathway in intra-atrial reentrant tachycardia using an automated voltage mapping program. J Cardiovasc Electrophysiol (2006) 0.75
Arrhythmogenic causes of chest pain in children. Pediatr Clin North Am (2010) 0.75
Editorial: the new pediatric cardiology paradigm: prevention and evidence. Curr Opin Cardiol (2012) 0.75
ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 4: recommendations for training guidelines in pediatric cardiac electrophysiology endorsed by the Heart Rhythm Society. J Am Coll Cardiol (2005) 0.75
Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death. Pediatr Cardiol (2013) 0.75
Subcutaneous array with active can implantable cardioverter defibrillator configuration: a follow-up study. Congenit Heart Dis (2008) 0.75